Digital Biomanufacturing Market A Look at Growth Drivers, Technologies, and Future Trends

Digital Biomanufacturing Market Assessment worth $ 58.31 Billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Biomanufacturing Market- by Application (Biomanufacturing Process Automation and Control, Bioprocess Optimization and Process Analytics, and Flexible Manufacturing), End-User (Biopharmaceutical Companies and Academic and Research Institutes), Technology (AI and IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics and Digital Twin Technologies, and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2030."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1296

The global digital biomanufacturing market , with a projected value of US$ 17.53 billion in 2021 , is poised for significant growth. According to the latest analysis by InsightAce Analytic, it is expected to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030. Digital technology in computer-aided design and computer-assisted machining processes is called "digital biomanufacturing."

These technologies can save costs and help to raise quality and safety standards by improving production processes. Microfluidic devices and other robotic automation systems are used in digital biomanufacturing to improve tissue engineering and cell culture precision. Additionally, it provides more efficient inventory control during manufacturing by utilizing embedded sensors that give the operators data via wireless networks so they can remotely monitor individual units.

Automated control systems enable real-time production monitoring that can help intelligent factories become more sustainable by lowering maintenance costs and the number of unsuccessful batches. Consequently, to maintain consistent product quality, increase yields, and reduce production costs, biomanufacturing companies must be able to independently and successfully manage bioprocesses in their ideal state.

This will stimulate the market. The growing requirement for biologics could be advantageous for the global industry of digital biomanufacturing. It would be beneficial to design a different manufacturing process that requires less human labour, has a smaller facility footprint for changes in unit activities, and is more flexible in terms of automation, scalability, and adaptability to other medicine modalities. A low return on investment and a lack of technical acceptance and knowledge are some challenges impeding the growth of the digital biomanufacturing industry.

Beyond in-depth profitability assessments, ROI calculations enable a business to create and use uniform project evaluation guidelines throughout a portfolio. A cyber biosecurity breach can cause direct injury to patients, disrupt production, undermine data security, and affect the efficacy of the global response to the pandemic. In the modern economy, where cutting-edge manufacturing technology and digital methods are becoming more and more prevalent, maintaining cybersecurity is a significant problem. Over the projected years, North America is expected to contribute significantly to the digital biomanufacturing market. Companies in North America are moving more and more toward digitizing their biologics.

To increase efficiency and save expenses, industrial enterprises also invest significant money in digital technology and related assets. Local governments fund research and development programs that install state-of-the-art sensor networks, process controls, and data analytics in industrial firms to boost productivity and energy efficiency. Furthermore, significant growth in the Asia Pacific Digital Biomanufacturing market is anticipated during the forecast period. This may be brought about by increased R&D spending, technological advancements, and the highly developed healthcare sector in the area.

Furthermore, growing interest in biopharmaceuticals and a sophisticated understanding of cutting-edge technology support regional development. Agilent Technologies Inc., Danaher Corporation, Donaldson Company, Inc., Bota Biosciences, Culture Biosciences, e-Matica Srl, Exponential Genomics, Inc. (Xenomics), FabricNano, Emerson Electric Co., General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, OVO Biomanufacturing, and Symphony Innovation, LLC are some of the prominent market players in the Digital Biomanufacturing market.

Recent collaborations and agreements in the market:

• In August 2021, BIO-Europe 2021 brought together global leaders in the biopharmaceutical and investment industries to build alliances that would support innovation and medical achievements. The framework of the event has been expanded to four 24-hour days to allow for partner engagements with delegates from all across the world.

BIO-Europe is produced by EBD Group, the world's leading partnering firm in the life sciences sector, with cooperation from the Biotechnology Innovation Organization (BIO).

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1296

Market Segments
Global Digital Biomanufacturing Market, by Application, 2022-2030 (Value US$ Mn)

• Biomanufacturing Process Automation and Control
• Bioprocess Optimization and Process Analytics
• Flexible Manufacturing

Global Digital Biomanufacturing Market, by End-User, 2022-2030 (Value US$ Mn)

• Biopharmaceutical Companies
• Academic and Research Institutes

Global Digital Biomanufacturing Market, by Technology, 2022-2030 (Value US$ Mn)

• AI and IoMT Solutions
• Process Analytical Technologies
• Data Analytics Software
• Predictive Analytics and Digital Twin Technologies
• Others

Global Digital Biomanufacturing Market, by Region, 2022-2030 (Value US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Digital Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• U.S.
• Canada

Europe Digital Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Digital Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Digital Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Digital Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Digital Biomanufacturing market
 To receive an industry overview and future trends of the Digital Biomanufacturing market
 To analyze the Digital Biomanufacturing market drivers and challenges
 To get information on the Digital Biomanufacturing market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Digital Biomanufacturing market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1296

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.